repinotan hydrochloride has been researched along with Cerebral Ischemia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, S; Fierus, M; Hacke, W; Kaste, M; Lyden, PD; Teal, P | 1 |
| Lutsep, HL | 1 |
| Krieglstein, J; Semkova, I; Wolz, P | 1 |
| Alessandri, B; Bullock, RM; Tsuchida, E | 1 |
| Fahrig, T; Horváth, E; Jork, R; Mauler, F | 1 |
1 review(s) available for repinotan hydrochloride and Cerebral Ischemia
| Article | Year |
|---|---|
Repinotan, A 5-HT1A agonist, in the treatment of acute ischemic stroke.
Topics: Acute Disease; Aged; Benzopyrans; Brain Ischemia; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Neuroprotective Agents; Serotonin Receptor Agonists; Stroke; Thiazoles; Treatment Outcome | 2005 |
1 trial(s) available for repinotan hydrochloride and Cerebral Ischemia
| Article | Year |
|---|---|
A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, tolerability, and pharmacokinetic/pharmacodynamic effects of a targeted exposure of intravenous repinotan in patients with acute ischemic stroke: modified Randomized Ex
Topics: Aged; Aged, 80 and over; Benzopyrans; Brain Ischemia; Dose-Response Relationship, Drug; Double-Blind Method; Drug Delivery Systems; Female; Humans; Infusions, Intravenous; Internationality; Male; Middle Aged; Stroke; Thiazoles | 2009 |
3 other study(ies) available for repinotan hydrochloride and Cerebral Ischemia
| Article | Year |
|---|---|
Neuroprotective effect of 5-HT1A receptor agonist, Bay X 3702, demonstrated in vitro and in vivo.
Topics: Animals; Benzopyrans; Brain; Brain Ischemia; Cell Death; Cell Survival; Cells, Cultured; Cerebral Infarction; Disease Models, Animal; Dose-Response Relationship, Drug; Glutamic Acid; Hippocampus; Male; Neurons; Rats; Rats, Inbred F344; Rats, Long-Evans; Serotonin Receptor Agonists; Thiazoles | 1998 |
The neuroprotective effect of a new serotonin receptor agonist, BAY X3702, upon focal ischemic brain damage caused by acute subdural hematoma in the rat.
Topics: Animals; Benzopyrans; Brain Ischemia; Dose-Response Relationship, Drug; Hematoma, Subdural, Acute; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Receptor Agonists; Thiazoles | 1999 |
Inhibition of evoked glutamate release by the neuroprotective 5-HT(1A) receptor agonist BAY x 3702 in vitro and in vivo.
Topics: Animals; Aspartic Acid; Benzopyrans; Brain Ischemia; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Space; Glutamic Acid; Hippocampus; Infarction, Middle Cerebral Artery; Male; Microdialysis; Neuroprotective Agents; Organ Culture Techniques; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Receptor Agonists; Synaptic Transmission; Thiazoles | 2001 |